Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Alpha-Synuclein Pre-Formed Fibrils Injected into Prefrontal Cortex Primarily Spread to Cortical and Subcortical Structures.
Journal: Journal of Parkinson's disease
Published: January 08, 2024
Alpha-synuclein pre-formed fibrils injected into prefrontal cortex primarily spread to cortical and subcortical structures and lead to isolated behavioral symptoms.
Journal: bioRxiv : the preprint server for biology
Published: February 13, 2023
Corrigendum to "α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration" [Neurobiol. Dis., Volume 105 (2017) Article 84, 98].
Journal: Neurobiology of disease
Published: September 27, 2021
Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain.
Journal: Molecular neurodegeneration
Published: May 27, 2021
Cortical alpha-synuclein preformed fibrils do not affect interval timing in mice.
Journal: Neuroscience letters
Published: May 10, 2021
COVID-19-associated necrotizing encephalopathy presenting without active respiratory symptoms: a case report with histopathology.
Journal: Journal of neurovirology
Published: March 07, 2021
Genetic background influences LRRK2-mediated Rab phosphorylation in the rat brain.
Journal: Brain research
Published: October 11, 2020
Sensitivity and specificity of phospho-Ser129 α-synuclein monoclonal antibodies.
Journal: The Journal of comparative neurology
Published: January 25, 2018
Breathing new life into an old target: pulmonary disease drugs for Parkinson's disease therapy.
Journal: Genome medicine
Published: October 21, 2017
α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration.
Journal: Neurobiology of disease
Published: January 30, 2017
G2019S-LRRK2 Expression Augments α-Synuclein Sequestration into Inclusions in Neurons.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: October 02, 2015
Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration.
Journal: The Journal of biological chemistry
Published: April 17, 2015
Last Updated: 09/26/2026